March 12, 2020 / 10:01 PM / 24 days ago

BRIEF-Lineage Cell Therapeutics Reports Quarterly Loss Per Share Of $0.03

March 12 (Reuters) - Lineage Cell Therapeutics Inc:

* LINEAGE CELL THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q4 REVENUE $1.2 MILLION VERSUS REFINITIV IBES ESTIMATE OF $1 MILLION

* ANTICIPATES NET OPERATIONAL SPEND FOR 2020 WILL BE ABOUT $16 MILLION

* QTRLY LOSS PER SHARE $0.03 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below